Pasquale Voce

Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma

E. Puxeddu, S. Moretti, N. Avenia, 2012, Front. Endocrin..

Targeted molecular therapies in thyroid carcinoma.

E. Puxeddu, S. Moretti, Pasquale Voce, 2009, Arquivos brasileiros de endocrinologia e metabologia.

Targeted molecular therapies in thyroid carcinoma Terapias moleculares direcionadas em câncer de tireoide

E. Puxeddu, S. Moretti, Pasquale Voce, 2009 .

Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1*

M. Santoro, R. Melillo, E. Puxeddu, 2016, The Journal of Biological Chemistry.

Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.

M. Santoro, S. Filetti, C. Orabona, 2014, The Journal of clinical endocrinology and metabolism.

Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells.

S. Filetti, D. Russo, E. Puxeddu, 2012, Thyroid : official journal of the American Thyroid Association.

Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes.

M. Ferrari, M. Gaspari, S. Filetti, 2014, Biomaterials.

Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors.

S. Filetti, D. Russo, E. Puxeddu, 2011, Oncology reports.